SCHEMBL761340

SCHEMBL761340

CNC(=O)C1CCCC1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18934846 0.97 HDAC8 (0.61)
SCHEMBL413228 0.97 HDAC8 (0.61)
SCHEMBL18938465 0.97 HDAC8 (0.61)
SCHEMBL13060381 0.97 HDAC8 (0.61)
SCHEMBL6917808 0.97 HDAC8 (0.61)
SCHEMBL24618011 0.97 HDAC8 (0.61)
SCHEMBL1678569 0.97 HDAC8 (0.61)
SCHEMBL18935496 0.97 HDAC8 (0.61)
SCHEMBL21212072 0.97 HDAC8 (0.61)
SCHEMBL1679607 0.97 HDAC8 (0.61)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 337 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-112752757-B Tyrosine amide derivatives as RHO-kinase inhibitors 奇斯药制品公司 2024-01-12 CN claimed
WO-2023229380-A1 HETEROCYCLIC COMPOUND AS DIACYLGLYCEROL KINASE INHIBITOR AND USE THEREOF 주식회사 엘지화학 2023-11-30 WO claimed
EP-3363788-A1 CANNABINOID RECEPTOR MODULATORS Arena Pharmaceuticals, Inc. (US) 2018-08-22 EP claimed
EP-2920172-A1 PURINE INHIBITORS OF HUMAN PHOSPHATIDYLINOSITOL 3-KINASE DELTA Merck Sharp & Dohme Corp. (US) 2015-09-23 EP claimed
US-9096598-B2 Azaindoles as Janus kinase inhibitors MERCK SHARP & DOHME CORP. (US) 2015-08-04 US claimed
WO-2014075393-A1 PURINE INHIBITORS OF HUMAN PHOSPHATIDYLINOSITOL 3-KINASE DELTA MERCK SHARP & DOHME CORP. (US) 2014-05-22 WO claimed
US-20130165412-A1 CANNABINOID RECEPTOR MODULATORS ARENA PHARMACEUTICALS, INC. 2013-06-27 US claimed
WO-2012145098-A1 USE OF ADENOSINE A3 RECEPTOR AGONISTS FOR TREATMENT OF NEUROPATHIC PAIN SAINT LOUIS UNIVERSITY (US) 2012-10-26 WO claimed
US-20120214766-A1 CANNABINOID RECEPTOR MODULATORS ARENA PHARMACEUTICALS, INC. 2012-08-23 US claimed
EP-2470508-A1 CANNABINOID RECEPTOR MODULATORS Arena Pharmaceuticals, Inc. (US) 2012-07-04 EP claimed
WO-2011025541-A1 CANNABINOID RECEPTOR MODULATORS ARENA PHARMACEUTICALS, INC. (US) 2011-03-03 WO claimed
WO-2008156831-A2 RENIN INHIBITORS VITAE PHARMACEUTICALS, INC. (US) 2008-12-24 WO claimed
EP-0053017-B1 AMIDE DERIVATIVES IMPERIAL CHEMICAL INDUSTRIES PLC (GB) 1985-02-20 EP claimed
EP-0045161-B1 AMIDES OF 4-OXO-5-AMIDOHEXANOIC ACID DERIVATIVES IMPERIAL CHEMICAL INDUSTRIES PLC (GB) 1984-03-14 EP claimed
EP-0053017-A1 Amide derivatives IMPERIAL CHEMICAL INDUSTRIES PLC (GB) 1982-06-02 EP claimed
EP-0045161-A1 Amides of 4-oxo-5-amidohexanoic acid derivatives IMPERIAL CHEMICAL INDUSTRIES PLC (GB) 1982-02-03 EP claimed
JP-2004702-A None JP disclosed
CN-119968355-A Cyclopentane compounds 橘生药品工业株式会社 2025-05-09 CN disclosed
EP-0053017-A1 Amide derivatives IMPERIAL CHEMICAL INDUSTRIES PLC (GB) 1982-06-02 EP disclosed
EP-0045161-A1 Amides of 4-oxo-5-amidohexanoic acid derivatives IMPERIAL CHEMICAL INDUSTRIES PLC (GB) 1982-02-03 EP disclosed